{
    "2021-05-27": [
        [
            {
                "time": "",
                "original_text": "明星基金扎堆重仓股：大举增持+超跌滞涨股仅6只",
                "features": {
                    "keywords": [
                        "明星基金",
                        "重仓股",
                        "大举增持",
                        "超跌滞涨"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "药明康德今日大宗交易成交14.90万股，成交价169.2元溢价0.0%",
                "features": {
                    "keywords": [
                        "药明康德",
                        "大宗交易",
                        "成交价",
                        "溢价"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "上市公司纷纷自投“搞私募”！宁德时代、药明康德等十多家纷纷出手，未来是“躺赢”还是“躺平”？",
                "features": {
                    "keywords": [
                        "上市公司",
                        "私募",
                        "宁德时代",
                        "药明康德"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "新能源"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "药明康德(603259)：王者出击 谁与争锋",
                "features": {
                    "keywords": [
                        "药明康德",
                        "王者出击"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "明星基金扎堆重仓股曝光，十年十倍股集中营，大举增持+超跌滞涨股仅6只",
                "features": {
                    "keywords": [
                        "明星基金",
                        "重仓股",
                        "十年十倍股",
                        "大举增持"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "创新药/医疗器械/生物医药…八大医药指数，未来谁会更牛？",
                "features": {
                    "keywords": [
                        "创新药",
                        "医疗器械",
                        "生物医药",
                        "医药指数"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "策略专题报告：“百年”行情电话会议纪要",
                "features": {
                    "keywords": [
                        "策略专题",
                        "百年行情",
                        "电话会议"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "诺威健康递表港交所，CRO行业格局生变？",
                "features": {
                    "keywords": [
                        "诺威健康",
                        "港交所",
                        "CRO",
                        "行业格局"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "从外资近期净流入和持仓风格变化角度：目前依然是核心资产牛市的延续而非普涨牛市",
                "features": {
                    "keywords": [
                        "外资",
                        "净流入",
                        "持仓风格",
                        "核心资产",
                        "牛市"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【医药生物*朱国广】CXO行业追踪报告：行业维持高景气，龙头公司空间广阔",
                "features": {
                    "keywords": [
                        "医药生物",
                        "CXO",
                        "高景气",
                        "龙头公司"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "速递 | 剑指T细胞疗法治疗实体瘤两大障碍，新锐计划1.5亿美元IPO",
                "features": {
                    "keywords": [
                        "T细胞疗法",
                        "实体瘤",
                        "新锐",
                        "IPO"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}